Affiliation:
1. National Medical Research Center for Children’s Health of the Ministry of Health of the Russian Federation; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russian Federation
2. National Medical Research Center for Children’s Health of the Ministry of Health of the Russian Federation
3. Russian Peoples’ Friendship University
4. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russian Federation
5. Surgut State University
Abstract
The aim of the study is to establish the prevalence of neuroendocrine hyperplasia of infancy (NEHI) in the structure of chronic lung diseases (CLD) and congenital lung malformations (CLM), clinical and instrumental diagnostics of these diseases in patients hospitalized at the National Medical Research Center for Children’s Health, Moscow over the period from 2012 to 2022. Materials and methods. Longitudinal non comparative single-center study of fourteen NEHI patients, diagnosed on the basis of 3 out of 4 signs of childhood CHILD-syndrome and the presence of typical CT signs of diseases, CLD and CLM patients. In all NEHI patients, the prevalence of clinical and instrumental signs was determined according to the scale, which includes 10 signs: onset of signs before the age of 12 months, delayed physical development, absence of drumstick symptom, absence of cough and wheezing (apart from episodes of respiratory infections), chest abnormalities, crackles, hypoxemia, tachypnea, retraction. Results. NEHI is a rare (0.53%) CLD in infants. The clinical scale for the diagnosis of NEHI is of practical importance in the early diagnosis of diseases; its use can reduce the prescription of drugs that are not effective for NEHI.
Publisher
National Medical Research Center for Childrens Health
Reference59 articles.
1. Das S., Langston C., Fan L.L. Interstitial lung disease in children. Curr. Opin. Pediatr. 2011; 23(3): 325–31. https://doi.org/10.1097/mop.0b013e3283464a37
2. Länger F., Werlein C., Soudah B., Schwerk N., Jonigk D. Interstitial lung disease in infancy and early childhood. Pathologe. 2021; 42(1): 25–34. https://doi.org/10.1007/s00292-020-00884-8
3. Carr L.L., Kern J.A., Deutsch G.H. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and neuroendocrine hyperplasia of infancy. Clin. Chest Med. 2016; 37(3): 579–87. https://doi.org/10.1016/j.ccm.2016.04.018
4. Ovsyannikov D.Yu., Belyashova M.A., Boytsova E.V., Asherova I.K., Bronin G.O., Volkov S.N., et al. The nosological structure and features of interstitial lung diseases in children during the first 2 years of life: results of a multicenter study. Neonatologiya: novosti, mneniya, obuchenie. 2018; 6(2): 93–104. https://doi.org/10.24411/2308-2402-2018-00022 (in Russian)
5. Bradley B., Branley H.M., Egan J.J., Greaves M.S., Hansell D.M., Harrison N.K., et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63(Suppl. 5): v1–58. https://doi.org/10.1136/thx.2008.101691